|
|||||
|
|
Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate |
|
| Authors: | Kim Ji Min Kim Binnari Kim Eunji Jang Minsun Cho Jun Hun Lee Hye Seung Kwak Yoonjin Huang Lingkang Krishnan Radha Bai Sally Y Mounawar Mounia Kim Kyoung-Mee |
| Institution: | 1.Department of Pathology, Ewha Womans University College of Medicine, 1071, Anyangcheon-ro, Yangcheon-gu, Seoul, South Korea ;2.Department of Pathology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea ;3.Center of Companion Diagnostics, Samsung Medical Center, 81 Irwon-ro, Irwon-dong, Gangnam-gu, Seoul, South Korea ;4.Samsung Medical Center, 81 Irwon-ro, Irwon-dong, Gangnam-gu, Seoul, South Korea ;5.Sungkyunkwan University School of Medicine, 25-2 Sungkyunkwan-ro, Myeongnyun 3(sam)ga-dong, Jongno-gu, Seoul, South Korea ;6.Seoul National University Hospital, 101, Daehak-ro Jongno-gu, Seoul, South Korea ;7.Seoul National University College of Medicine, 103, Daehak-ro Jongno-gu, Seoul, South Korea ;8.Seoul National University College of Medicine, 1 Gwanak-ro, Gwanak-gu, Seoul, South Korea ;9.Merck & Co., Inc., Rahway, NJ, USA ; |
| Abstract: | Molecular Diagnosis & Therapy - The PD-L1 IHC 22C3 pharmDx used on the Dako Autostainer Link 48 (ASL48) staining platform is an established method for assessing programmed death-ligand 1... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |